TWIST1 and esophageal squamous cell carcinoma: Our results confirmed the potential of TWIST1 as a proper therapeutic target for cancer treatment to inhibit EMT progress and the cancer stem-cell-like phenotype through its regulatory role of CSC markers’ gene expression, expanding insight into the TWIST1 biology in ESCC and paving the road to an efficient targeted therapy.